Pulmonary disease

‘I’d need a drink’: WaPo deep dive on clinic firm Lung Health Institute

H-CYTE-Ann-Sells-Miller

Washington Post reporters William Wan and Laurie McGinley have a new piece on the unproven regenerative clinic firm the Lung Health Institute. This article has a number of surprises and new insights. Previously the Lung Health Institute was called just the Lung Institute. It was recently acquired by the publicly-traded company H-CYTE, stock symbol HCYT. In the …

‘I’d need a drink’: WaPo deep dive on clinic firm Lung Health Institute Read More »

Stem cells for COPD including emphysema: are we there yet?

Chronic obstructive pulmonary disease (COPD) is a relatively common, often debilitating illness, which has a major impact on the people of the world. In the U.S. alone, COPD costs the country almost $50 billion a year not to  mention untold suffering. Most of us know someone who has COPD. COPD is an umbrella term that …

Stem cells for COPD including emphysema: are we there yet? Read More »